Matthew Bates Selected Research

Matthew Bates Research Topics

Disease

13	Tuberculosis (Tuberculoses) 01/2018 - 07/2011
8	Infections 11/2022 - 04/2013
3	Cardiac Arrhythmias (Arrythmia) 12/2023 - 05/2019
3	Ventricular Tachycardia 12/2023 - 11/2021
3	Phototoxic Dermatitis (Phototoxicity) 02/2023 - 10/2019
3	Pneumonia (Pneumonitis) 06/2022 - 09/2015
2	Neoplasms (Cancer) 02/2023 - 12/2022
2	Wounds and Injuries (Trauma) 01/2022 - 01/2018
2	Heart Failure 01/2018 - 01/2017
2	HIV Infections (HIV Infection) 07/2016 - 05/2012
2	Noncommunicable Diseases 10/2015 - 05/2012
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 03/2015 - 01/2013
2	Respiratory Tract Infections (Respiratory Tract Infection) 11/2014 - 11/2014
1	Cardiomyopathies (Cardiomyopathy) 12/2023
1	Central Nervous System Infections (Central Nervous System Infection) 10/2023
1	Colonic Neoplasms (Colon Cancer) 02/2023
1	Breast Neoplasms (Breast Cancer) 12/2022
1	Lymphoma (Lymphomas) 09/2022
1	Surgical Wound 01/2022
1	COVID-19 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2018
1	Latent Infection 01/2018
1	Dengue (Dengue Fever) 01/2017
1	Injection Site Reaction 01/2017
1	Severe Dengue 01/2017
1	Stroke (Strokes) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Systolic Heart Failure 01/2017
1	Neonatal Sepsis 07/2016
1	Malnutrition (Nutritional Deficiencies) 07/2016
1	Meningitis 07/2016
1	Proteinuria 09/2015
1	Severe Acute Respiratory Syndrome 11/2014
1	Human Influenza (Influenza) 11/2014
1	Poliomyelitis (Polio) 04/2013
1	Extensively Drug-Resistant Tuberculosis 09/2010

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 01/2022 - 07/2011
4	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 04/2013
4	AntigensIBA 07/2022 - 03/2015
3	Volatile Organic CompoundsIBA 01/2022 - 10/2015
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2013 - 09/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2023 - 10/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2023 - 12/2022
2	Photosensitizing Agents (Photosensitizers)IBA 02/2023 - 12/2022
2	SaltsIBA 12/2022 - 10/2019
2	AntibodiesIBA 11/2022 - 04/2013
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2016 - 11/2014
2	Nucleic AcidsIBA 10/2015 - 11/2014
1	Trifluoroacetic Acid (Trifluoroacetate)IBA 02/2023
1	Singlet OxygenIBA 02/2023
1	MolybdenumIBA 02/2023
1	Volatile Fatty AcidsIBA 02/2023
1	LigandsIBA 02/2023
1	AnionsIBA 12/2022
1	CationsIBA 12/2022
1	COVID-19 VaccinesIBA 11/2022
1	SARS-CoV-2 spike proteinIBA 11/2022
1	Valganciclovir FDA Link 06/2022
1	AS 35IBA 06/2022
1	Anti-Arrhythmia AgentsIBA 11/2021
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	Phosphocreatine (Neoton)IBA 01/2018
1	CYD-TDV vaccineIBA 01/2017
1	ParaffinIBA 01/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	N 30IBA 01/2017
1	Dengue VaccinesIBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2015
1	lipoarabinomannan (LAM)IBA 09/2015
1	Gatifloxacin (Zymar)FDA Link 03/2015
1	Moxifloxacin (Avelox)FDA Link 03/2015
1	FluoroquinolonesIBA 03/2015
1	Antiviral Agents (Antivirals)IBA 11/2014
1	Anti-Infective Agents (Microbicides)IBA 11/2014
1	MicronutrientsIBA 04/2013
1	Isoniazid (Ftivazide)FDA LinkGeneric 09/2010

Therapy/Procedure

9	Therapeutics 12/2023 - 05/2012
2	Photochemotherapy (Photodynamic Therapy) 02/2023 - 12/2022
2	Duration of Therapy 10/2015 - 03/2015
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2023
1	Catheter Ablation 11/2021
1	Radiotherapy 11/2021
1	Catheters 05/2019
1	Radiofrequency Ablation 05/2019
1	Highly Active Antiretroviral Therapy (HAART) 12/2018
1	Art Therapy 07/2016